Filter posts

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued …

IP at the 2014 BIO International Convention

Securing and maintaining intellectual property protection for the next generation of biotech innovation faces new …

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Corporate-Sponsored University Research Valuable for Further Innovation

New research published in Nature, Technology Transfer: Industry-funded academic inventions boost innovation, provides data undermining …

Gene Patent Questions Remain: USPTO Issues Examiner Guidelines

The new Patent Office guidance, issued March 4, extends the Supreme Court’s legal logic into …

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face …

Report Shows World's Weakest IP Environments

There is clear link between a country’s rate of economic development and the strength of …

TPP and IP: The Economic Benefits of a Pacific Trade Agreement

Ndp Analytics recently published a study on the economic benefits of intellectual property rights (IP) …

Patently Biotech’s Top Articles of 2013

Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions, …

Universities Express Concerns About Recently Passed House “Innovation Act”

Earlier this month, the House passed the Innovation Act (H.R. 3309), which seeks to address …